Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
GHRS
GHRS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
GHRS News
Trump Signs Executive Order to Accelerate Psychedelic Research
5h ago
CNBC
Trump Signs Executive Order on Psychedelics, Boosting Compass Pathways Stock
10h ago
Yahoo Finance
Trump Signs Executive Order to Accelerate Psychedelic Drug Reviews
12h ago
Newsfilter
Trump Administration to Examine Safety of Psychedelic Drug for PTSD
2d ago
Yahoo Finance
Trump Administration to Examine Ibogaine Research for PTSD Funding
4d ago
stocktwits
GH001 Shows Promising Results in Treatment-Resistant Depression Study
Mar 25 2026
Newsfilter
Helus Pharma Advances New Drug for Anxiety Treatment
Mar 09 2026
Newsfilter
Helus Pharma Advances Mental Health Treatments with Promising Phase 2 Results
Mar 09 2026
PRnewswire
GH Research Reports FY 2025 Financial Results
Mar 05 2026
seekingalpha
Helus Pharma Advances Mental Health Drug Development
Feb 27 2026
Newsfilter
Helus Pharma Advances Psychedelic Drug Clinical Trials
Feb 27 2026
PRnewswire
US Stocks Close Higher, S&P 500 Hits One-Week High
Jan 06 2026
NASDAQ.COM
US Stock Indices Rise with Energy Stocks Leading Gains
Jan 05 2026
NASDAQ.COM
Momentus Inc. Shares Surge 57% Following Fuel Tank Development Announcement
Jan 05 2026
Benzinga
US Stocks Rise as Energy Shares Surge on Venezuela Situation
Jan 05 2026
NASDAQ.COM
Altimmune Inc Receives FDA Breakthrough Therapy Designation for Pemvidutide, Shares Surge 23.6%
Jan 05 2026
Benzinga
Show More News
